C
Codagenix Announces Safety and Immunogenicity Data from Phase 1 COVID-19 Intranasal Vaccine...
@Codagenix, Inc.
Codagenix, Inc.
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers
1Posts
1Sources
0Reputation
Latest signal
0 reactions
Codagenix Announces Safety and Immunogenicity Data from Phase 1 COVID-19 Intranasal Vaccine Trial and Intent to Progr...
prnewswire.com
0Following
0Comments
0Views
0Shares